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Abstract
Background: Relapsing fever (RF) spirochetes are notable for multiphasic antigenic variation of polymorphic outer
membrane lipoproteins, a phenomenon responsible for immune evasion. An additional role in tissue localization is
suggested by the finding that isogenic serotypes 1 (Bt1) and 2 (Bt2) of the RF spirochete Borrelia turicatae, which differ only
in the Vsp they express, exhibit marked differences in clinical disease severity and tissue localization during infection.
Methodology/Principal Findings: Here we used known vsp DNA sequences encoding for B. turicatae and Borrelia hermsii
Vsp proteins with variable regions and then studied whether there are differences in disease expression and tissue
localization of their corresponding serotypes during mouse infection. For sequence and structural comparisons we focused
exclusively on amino acid residues predicted to project away from the spirochetes surface, referred to as the Vsp dome.
Disease severity and tissue localization were studied during persistent infection with individual or mixed serotypes in SCID
mice. The results showed that all Vsp domes clustered into 3 main trunks, with the domes for B. turicatae Vsp1 (BtVsp1) and
BtVsp2 clustering into separate ones. B. hermsii serotypes whose Vsp domes clustered with the BtVsp1 dome were less
virulent but localized to the brain more. The BtVsp2 dome was the oddball among all and Bt2 was the only serotype that
caused severe arthritis.
Conclusion/Significance: These findings indicate that there is significant variability in Vsp dome structure, disease severity,
and tissue localization among serotypes of B. hermsii.
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Introduction
Relapsing fever (RF) is an arthropod-borne, spirochetal disease
of humans caused by infection with different Borrelia species [1]. A
characteristic feature of RF is two or more periods of high fever
and bacteremia separated by afebrile periods during low
bacteremia. This pattern of relapses and remissions is explained
by the sequential spontaneous appearance and clearance of
isogenic serotypes that are antigenically distinct from the previous
ones and from the ones that follow them [1,2]. Major outer
membrane lipoproteins that are highly variable in sequence and
are the target of antibody-mediated clearance define the serotype
[3,4]. These proteins in the new world RF spirochetes B. hermsii
(Bh) and B. turicatae (Bt) come in two sizes, variable small proteins
(Vsp) of ,22 kDa and variable large proteins (Vlp) of ,37 kDa
[5,6]. By spontaneously switching expression at a single expression
locus by gene conversion from silent genes RF spirochetes evade
antibody-mediated clearance [2]. Studies in our laboratory
indicate that another consequence of serotype switch is changes
in disease severity and tissue localization during infection:
Serotype 1 of B. turicatae (Bt1), defined by expression of Vsp1,
localizes to the brain in 5- to 10-fold higher numbers than serotype
2 (Bt2), defined by expression of Vsp2 [7,8,9,10]. Conversely, Bt2
infection features 5- to 10-fold higher pathogen load in the blood,
joints, heart, and skin than Bt1 [11,12]. Furthermore, Bt2 causes
more severe systemic disease than Bt1, including conjunctivitis,
ruffled skin, tibiotarsal arthritis, reduced spontaneous activity, and
neonatal mortality [7,8,9,10,12,13,14,15,16,17].
There have been no previous studies of the virulence and
tropism of isogenic serotypes in B. hermsii. However, the previous
sequencing of all vsp genes from B. hermsii strain HS1 by Barbour
and colleagues [5,18] gave us the opportunity to study whether
differences similar to what we observed with B. turicatae do exist
with B. hermsii. Furthermore, because of the recent characteriza-
tion of crystal structures from Vsp1 of B. turicatae [19,20] and
OspC from B. burgdorferi [21] we were able to study the
heterogeneity of the Vsp variable dome region using computer
homology modeling. The results revealed significant heterogeneity
PLoS ONE | www.plosone.org 1 October 2009 | Volume 4 | Issue 10 | e7597in the Vsp dome region and in the virulence and tissue localization
of B. hermsii serotypes.
Methods
Bacterial strains
B. hermsii strain HS1 [22] and B. turicatae Oz1 strain [8] were
used for all experiments. The identity of B.hermsii serotypes 3 and
13 was confirmed by PCR amplification and sequencing of the
expressed vsp gene from spirochetes cultured from infected tissues
[22]. The identity of Bt1 and Bt2 was determined by immunoblot
with anti Vsp1 or Vsp2 monoclonal antibodies as before [23,24].
All borrelias were cultured in BSK-H media supplemented with
6% rabbit serum (Sigma). Peak bacteremia and spirochetal
viability were determined using phase-contrast microscopy with
a Petroff-Hauser chamber [25].
Mouse Infections
All mice used in these experiments were 4–5 week old female
CB17-SCID (severe combined immunodeficiency) or Balb/c mice
(Charles River). Mice were inoculated intraperitoneally with a total
of 10
3 viable spirochetes from BSK-H cultures or pooled necropsy
plasma suspended in 200 mL of PBS. Mice sham-inoculated with
PBS or with a non-infectious B. burgdorferi B31 derivative [26] were
used as negative controls. All mice were maintained in a germ free
environment and housed in accordance with the Animal Welfare
Act in facilities accredited by the AAALAC (at UMDNJ-New Jersey
Medical School). To generate a diverse mixture of B. hermsii
serotypesweinoculatedimmunocompetentBalb/cmice(N=3)with
500 spirochetes each of Bh7 and Bh19 (a kind gift from Dr. Alan G.
Barbour, UC Irvine, CA) and 7 days later harvested the blood
containing the first relapse serotypes from each mice, pooled it, and
amplified it by inoculation into SCID mice (N=3) to grow to peak
bacteremia without negative selection from serotype-specific
antibodies. This amplified population, referred to as R1, was then
inoculated into a new group of Balb/c mice (N=3) and 7 days later
the process was repeated by collecting the blood from each mouse,
pooling it, and inoculating it back into new SCID mice to grow to
peak bacteremia. The process was similarly repeated with this
second group of relapse serotypes, referred to as R2. A total of 5
such cycles of negative selection in Balb/c mice followed by
amplification in SCID mice were completed, followed by a final
amplification step ofoneeachofalltheR1toR5aliquotsintoa final
group of 4 SCID mice. Pooled plasma from these 4 SCID mice,
referred to as relapse mix, was predicted to contain a highly diverse
mixture of relapse serotypes; it was aliquoted and frozen in 10%
DMSO for later use.
Clinical examination
All mice were examined by an examiner (MS) masked to
infection status and serotype. Severity of clinical disease was
assessed upon disease onset every 3–4 days for 2 weeks using the
following semi-quantitative clinical score: (A) Skin (fur): nor-
mal=0; ruffled=1; ruffled and dry=2. (B) Eyes (conjunctival
secretion): normal=0; mucous=1; mucous and closing of
eyelids=2. (C) Spontaneous activity: normal=0; reduced=1;
very little/absent=2. (D) Tibiotarsal joints: normal=0; swol-
len=1; swollen and red=2. The severity of arthritis was also
measured quantitatively on the most swollen tibiotarsal joint with a
Vernier caliper [8].
Tissue and Fluid Collection
Mice were euthanized by inhalation of isoflurane. Heparin was
used as an anticoagulant for blood collection by heart puncture.
Necropsy plasma was obtained by whole-blood centrifugation for
5 sec in a tabletop centrifuge. Total body perfusion with 30 mL
PBS followed by rinsing of the brain with 1 mL PBS twice in
sterile 2-mL microfuge tubes (Sarstedt Inc, Newton, NC) were
used to minimize residual blood contamination of the brain [22].
The whole brain was homogenized in sterile PBS using plungers of
sterile, 1-mL plastic syringes (Becton Dickinson & Co., Mountain
View, CA) followed by further homogenization using glass
microbeads (Lysing Matrix D, MP Biomedicals, Irvine CA) with
the FastPrep-24H system at 4.0 M/s for 30 seconds twice (MP
Biomedicals, Irvine, CA) and stored frozen at 280uC for DNA
extraction later on. Pellets of necropsy plasma were prepared by
centrifugation at 13,000 rpm for 20 min at room temperature.
DNA extraction and TaqMan PCR
DNA was extracted from volumes of brain homogenates
equivalent to 10 mg of brain or from pellets of whole necropsy
plasma using the QIAamp DNA MicroH kit (Qiagen Inc.,
Turnberry, CA), eluted in 100 mL TE, and kept frozen at
280uC. TaqMan PCR reaction used 100 ng of brain or 10 ng of
plasma pellet DNA. TaqMan assays were run in multiplex, with
the housekeeping gene and target gene in the same well, and in
singleplex, with the housekeeping gene and target gene in different
wells, with pre-designed mouse 18S rRNA primers and probe
(Applied Biosystems Mm4308329) to control for the amount of
host input DNA. Custom designed primers and probes for the B.
hermsii chromosomal rrs gene for 16S ribosomal RNA and the
linear plasmid genes vsp3, vsp13, vsp2 and vsp27 were made by
Applied Biosystems (Table 1). We calculated the DDCt number by
subtracting the Ct for each vsp gene from the Ct for the 16S rRNA
borrelial chromosomal gene and adjusted the results for the Ct
Table 1. Taqman primers and probe sets used for relative
quantification of B. hermsii genes.
16S rRNA
Forward Primer 59-GCGTAAAATAC CACAGCTCAACTG-39
Reverse Primer 59-CCCCTATCAGAC TCTAGTCATGCA-39
Probe
a 59-TTTCCAGC ATATTCCC-39
vsp3
Forward Primer 59-AGTGAAGCATTC GTAACCCAAGTAA-39
Reverse Primer 59-CATGTGCATCA GTAACACCTTCTTT-39
Probe 59-ATCAAAGCAT ACTGATCTTGC-39
vsp13
Forward Primer 59-CAAGTTGTTGCTA TTAAGACTGCAAGT-39
Reverse Primer 59-GCATCGTCATTAC TAACCTCGTTTT-39
Probe 59-CCAAGTTCA GCATTTTT-39
vsp2
Forward Primer 59-ATGTAGGTACTAAATTGGACGGGTTA-39
Reverse Primer 59-TTGCTTAAGAATGCTGTACCTTTACTCT-39
Probe 59-TGGAATTTCTGAAGATATTAAG-39
vsp27
Forward Primer 59-GGTATTTAGTGTGGCTACAACTATAGA-39
Reverse Primer 59-GCCTTAGCCTCAACATCTTTAACTTT-39
Probe 5-ACAAGTAGCACAATCTC-39
aAll probes were FAM-labeled; for the origin of the vsp primers and probes see
Table S1 and references [5] for the vsp and [46] for the 16S rRNA genes.
doi:10.1371/journal.pone.0007597.t001
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18S rRNA signal was obtained, as was the case in some plasma
pellet samples, a Ct of 40 was used. The sensitivity to detect any of
the Bhvsp genes in brain decreased from one and a half to almost 4
fold when the samples were run in multiplex compared to
singleplex because of the abundance of host relative to borrelial
DNA. All samples were run in triplicate as relative quantification
assays on the ABI Prism 7500 real time PCR system (Applied
Biosystems, Alameda, CA). Samples with H2O instead of DNA
and DNA from uninfected mice brains (only for experiments with
borrelia genes) were used as negative controls.
Computer structural homology modeling of Vsp domes
Computer homology models were prepared for Vsps corresponding
to several Vsp serotypes from B. hermsii HS1 and B. turicatae Oz1 strains.
For this, five known crystallographic source structures were used,
including three different B. burgdorferi OspC variants (B31, N40, HB19)
[21,27] and B. turicatae Vsp1 in two different crystal forms [19,20]. The
Protein Databank ids for these structures are 1yjg and 2ga0 for BtVsp1,
1g5z for Bb N40 OspC, 1f1m for Bb HB19 OspC, and 1ggq for Bb
B31 OspC. All five structures are defined to near-atomic resolution
(1.8–2.7 A ˚) and all have reasonable model statistics and geometry (Rfree
21.5–27.5%, r.m.s. bonds 0.004–0.022 A ˚, no Ramachandran plot
outliers). The initial step in the homology modeling process was careful
preparation of a multiple sequence alignment of each Vsp target with
the crystal structures, guided by inspection of the superimposed models
using molecular graphics. Within variable loops, gaps and/or insertions
were positioned to maximize similarity of residue substitutions. For
example, introduction of staggered gaps into the alignment between
BtVsp1 and BtVsp2 better conserves hydrophobic burial properties of
a variable loop between helices 2 and 3. The multiple sequence
alignments and single-subunit structural models were the inputs to
automated homology modeling using the program Modeller [28] and/
or to the Swiss Model server [29]. Full Vsp dimers were then generated
from single subunit coordinate sets by application of two-fold
symmetry; this procedure is simpler than generating full dimer
homology models. All model dimers were inspected for problem areas
(Ramachandran outliers, high energy areas, poor geometry areas,
clashes at the dimer interface). Problems were corrected either by
revision of the multiple sequence alignment, or by manual adjustments
of the model, guided by the crystal structures. Model coordinates were
subsequently optimized with respect to standard geometry [30] and
constrained to obey perfect two-fold symmetry using Refmac without
X-ray restraints [31]. The homology models lacked only the N-
terminal and C-terminal residues that are not present in the crystal
structures. Pairwise alignment scores of Vsp dome region sequences
were obtained using ClustalW (Version 7.6.0.87). All known Vsp
proteins from B. hermsii HS1 and B. turicatae Oz1 Vsp’s were included in
this analysis (Table S1).
Statistical analyses
All statistical analyses used GraphPad PRISM Version 5.01. To
compare the amounts of vsp DNA in the brain and blood we used
one way ANOVA with Bonferroni’s multiple comparison tests. To
compare peak bacteremia in necropsy blood we used t-tests. We
also used t-tests to compare the severity of clinical scores among
individual borrelia serotypes. The error bars represent standard
deviations. P values #0.05 were considered significant.
Results
Computer homology modeling of Vsp dome regions
We began the study by examining the differences between Vsp1
(BtVsp1) and Vsp2 (BtVsp2) of B. turicatae by computer homology
modeling. For this we predicted the structure of BtVsp2 using its
known DNA sequence based on 5 known crystal structures from
Vsp and OspC proteins [32], two from B. turicatae Vsp1 (BtVsp1),
and 3 from Borrelia burgdorferi OspC [21,33]. A comparison of the
generated BtVsp2 structure with that of BtVsp1 revealed striking
differences restricted to the portion that projects away from the
spirochetal surface, referred to as the Vsp dome (Figure 1).
Although both domes are hydrophilic, the BtVsp2 dome has many
fewer charged residues. As a result, the BtVsp1 dome has higher
polarity and a more negative electrostatic potential.
Cluster analysis of Vsp domes from B. turicatae and B.
hermsii
Because the differences between BtVsp1 and BtVsp2 proteins is
in their dome region, next we did a cluster analysis of the dome
region from all known Vsp proteins from B. hermsii (N=12) and B.
turicatae (N=5) using the ClustalW algorithm (Table S1) that treats
multiple alignments like single sequences and compares them in a
two by two progression to cluster them by similarity. The resultant
dendrogram showed that all Vsp domes clustered into 3 branches,
with the BtVsp2 in the upper branch and the BtVsp1 dome in the
middle branch (Figure 2). We also calculated pairwise alignment
scores of the discontinuous sequences that constitute the dome
regions of BtVsp1 and BtVsp2 for all 12 known Vsp proteins from
B. hermsii. This revealed that BhVsp3 and BhVsp24 were the B.
hermsii Vsp domes most similar to the BtVsp1 dome, with scores of
48 and 45, respectively (Table 2). The BhVsp3 dome was more
similar to the BtVsp1 dome than to the BtVsp2 dome, as reflected
by a gap of 8 points between the two scores. The BhVsp13 dome
had the highest pairwise alignment score with the BtVsp2 dome,
48 points, but only a gap of 4 points with the BtVsp1 dome. This
indicated that the BhVsp3 dome was more similar to the BtVsp1
dome than the BhVsp13 dome was to the BtVsp2 dome.
Differences in clinical disease expression among B.hermsii
serotypes
We selected the two serotypes of B. hermsii strain HS1 whose Vsp
domes had the highest pairwise alignment scores compared with
BtVsp1 and BtVsp2, B. hermsii serotypes 3 (Bh3) and 13 (Bh13),
respectively (Table 2), to study their virulence and tissue
dissemination during infection in comparison to Bt1 and Bt2.
For this, groups of four 4–5 week old female CB17-SCID mice
were inoculated intraperitoneally with 10
3 spirochetes of each
selected serotype and examined clinically every 3–4 days for 3
weeks by a masked observer (MS). Mice inoculated with a non-
infectious derivative of B. burgdorferi B31 [26] was included as
negative control. Clinical disease severity was scored semiquanti-
tatively for skin, eyes, joints, and spontaneous activity, and
quantitatively for tibiotarsal joint swelling using a vernier caliper
[8]. The results revealed that mice inoculated with Bh3 had similar
disease severity scores than mice inoculated with Bt1 (Figure 3A).
In contrast, mice inoculated with Bh13 had disease severity scores
for skin and spontaneous activity that were more similar to Bt2.
Interestingly, Bt2 was the only serotype that caused prominent
tibiotarsal joint swelling (Figure 3B). None of the mice that were
inoculated with the non-infectious B31 derivative developed any
signs of disease. Paired comparisons of disease severity scores
among the 4 serotypes showed that Bt2 was the most virulent,
resulting in significantly worse disease scores for all 4 clinical
measures compared to Bt1, for 3 of the 4 measures compared with
Bh3, and for 2 of 4 measures compared to Bh13 (Table 3). Bh13
was the second most virulent with worse clinical disease severity
scores in 2 out of 4 measures compared to Bt1 or Bh3. Bt1 and
Borrelia hermsii Serotypes
PLoS ONE | www.plosone.org 3 October 2009 | Volume 4 | Issue 10 | e7597Figure 2. Phylogenetic tree of the Variable small protein (Vsp) ‘‘dome’’ region from 12 B. hermsii (Bh) and 5 B. turicatae (Bt) serotypes.
The tree is based on sequence alignment of amino acids from the dome Vsp region, defined by residues 67–183 in BtVsp1 (see materials and
methods for details and Table S1) using ClustalW. Three main branches were identified with BtVsp1 clustering in the middle branch and BtVsp2 in the
upper branch.
doi:10.1371/journal.pone.0007597.g002
Figure 1. Computer homology modeling of B. turicatae Vsp1 (BtVsp1) and Vsp2 (BtVsp2). Vsp variable dome regions were modeled based
on two crystal structures of BtVsp1 and OspC from 3 different Borrelia burgdorferi strains. Panels A&D show the sagital views, panels B&E the axial
views, and panels C&F the electrostatic potential field of the axial view. Each amino acid corresponds to a letter and a color which represents their
polarity with red for high polarity and dark blue for low polarity. Notice the dome of BtVsp1 is much more polar and its negative electrostatic
potential is more pronounced than that of BtVsp2 (D=aspartic acid, E=glutamic acid, K=lysine, R=arginine, H=histidine, S=serine, T=threonine,
N=asparagine, Q=glutamine, A=alanine, G=glycine, P=proline, L=leucine, I=isoleucine, V=valine).
doi:10.1371/journal.pone.0007597.g001
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similar to B. turicatae, there are differences in the systemic virulence
of B. hermsii serotypes.
Differences in peak bacteremia with B. hermsii serotypes
Next we studied whether there were differences in peak
bacteremia among B. hermsii serotypes. For this we measured
peak bacteremia during persistent infection [34] in SCID mice 3
weeks after inoculation with Bh3 or Bh13 and compared them
with SCID mice similarly inoculated with Bt1 or Bt2. Bacteremia
was measured using phase-contrast microscopy of tail vein blood
with a Petroff-Hausser chamber. The results showed that Bh13
caused higher peak bacteremia than Bh3: their mean (SD) peak
bacteremia per ml was 4.5610
7 (1.22610
7) and 1.67610
7
(1.04610
7), respectively (p,0.05). Consistent with previous results,
Bt2 also caused higher mean (SD) peak bacteremia per ml than
Bt1, 8.25610
7 (4.87610
7) versus 8.75610
6 (2.5610
6), respectively
(p,0.05). Overall there was no difference in peak bacteremia
between B. hermsii and B. turicatae when both serotypes were
considered together (p=0.54). We concluded that, similar to B.
turicatae, peak bacteremia differs among B. hermsii serotypes.
Differences in dissemination to the brain among
B.hermsii serotypes
Next we compared the ability of B. hermsii serotypes to infect the
brain. For this we wanted to include serotypes representing all
three branches from the Vsp dome homology dendrogram
(Figure 2). However, we could not get clonal populations from
any Bh serotypes from the upper branch. As an alternative
approach, we inoculated into the same group of SCID mice
(N=8) a diverse mixture of B. hermsii serotypes that we had
prepared by serial passage of relapse serotypes into immunocom-
petent mice (see methods for details). Unlike the previous
experiments of SCID mice inoculated with individual serotypes,
this novel approach required a method capable of differentiating
multiple serotypes simultaneously present in each mouse. For this
we first tried standard PCR amplification of the expressed vsp gene
that uses a forward primer specific for the vsp promoter and
reverse primers specific for conserved regions near the 39 of vsp
genes [22]. However, the results were inconsistent and of low
yield, especially in the brain. As an alternative we turned to
TaqMan PCR because of its superior sensitivity due to a shorter
length of the amplicons (,80 bp) relative to expressed vsp gene
PCR (.1 Kbp). However, a limitation of the vsp TaqMan
approach was that all serotypes carry both silent and expressed
vsp genes and therefore any vsp TaqMan primers and probe set will
measure spirochetes independently of the vsp gene being
expressed. To address this limitation we took advantage of the
fact that each serotype carries at least one extra copy of the vsp
gene being expressed [35]. Accordingly, each serotype is expected
to carry a higher vsp gene copy number when tested with TaqMan
primers and probe sets specific for their expressed vsp gene than
when examined with primer and probe sets specific for non-
expressed, or silent, vsp genes. For this we prepared TaqMan
primers and probe sets specific for B. hermsii vsp2, vsp3, vsp13, and
vsp 27, corresponding to serotypes from all 3 branches of the Vsp
homology dome dendrogram (Figure 2). All custom made
TaqMan primers and probes were found to have high amplifica-
Table 2. Pairwise alignment scores of the discontinuous
sequences that constitute the dome regions of all known B.
hermsii Vsp’s with Vsp1 (BtVsp1) and Vsp2 (BtVsp2) of B.
turicatae.
B. hermsiiVsp B. turicatae Vsp Score Gap
BtVsp1 BtVsp2 BtVsp1-BtVsp2
BhVsp1 38 44 26
BhVsp2 43 41 2
BhVsp3 48 40 8
BhVsp6 40 39 1
BhVsp8 39 36 3
BhVsp11 37 30 7
BhVsp13 44 48 24
BhVsp22 44 46 22
BhVsp24 45 42 3
BhVsp26 43 42 1
BhVsp27 33 40 27
BhVsp33 42 46 24
doi:10.1371/journal.pone.0007597.t002
Figure 3. Severity of clinical disease in SCID mice persistently
infected with isogenic serotypes of B. turicatae (Bt1 or Bt2) or B.
hermsii (Bh3 or Bh13). Mean (SD) sum clinical severity scores (panel
A) and tibiotarsal joint swelling measured by a Vernier caliper (in mm,
panel B) in groups of 4 SCID mice each studied by a masked examiner
every 3–4 days for 3 weeks during infection with serotypes 1 (Bt1) or 2
(Bt2) of B. turicatae or serotypes 3 (Bh3) or 13 (Bh13) of B. hermsii. Notice
greater disease severity scores and tibiotarsal joint swelling in mice
infected with Bt2. Also notice the greater similarities between Bt1 and
Bh3 and between Bt2 and Bh13. Table 3 shows the p values for the
paired comparisons among individual serotypes.
doi:10.1371/journal.pone.0007597.g003
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mouse housekeeping gene 18S rRNA (Table 4). In most cases they
turned out to be highly specific because they did not amplify DNA
from B. turicatae (Table S2) or B. burgdorferi B31 (not shown). We
demonstrated the validity of the vsp TaqMan approach by
measuring blood and tissue samples from SCID mice that had
been inoculated with Bh13 using vsp13 and vsp3 TaqMan sets. The
results showed that the vsp gene copy number was twice as much
with the vsp13 than with the vsp3 primers and probe set (Table S3).
We then used the vsp TaqMan approach to compare the relative
abundance of vsp2, vsp3, vsp13, and vsp27 gene copy number in the
‘‘relapse mix’’ inoculum (see methods for details). The results
showed differences among the 4 vsp genes, with the highest gene
copy number for vsp3 and the lowest for vsp2 (Table S2). We then
proceeded to use the vsp TaqMan approach to compare the
relative neuroinvasiveness of these 4 B. hermsii serotypes. For this
we used blood and brain from 8 SCID mice that had been
inoculated intraperitoneally with 10
4 spirochetes of the ‘‘relapse
mix’’ inoculum and necropsied 2 weeks later. The results were
analyzed using the DDCt method [36] which controls for the
amount of host input DNA and expressed as the mean (SD) log 2
negative number (2
2DDCt). This analysis revealed significant
differences in the vsp gene copy number between these 4 serotypes
in the brain (Figure 4a, p,0.01 by one way ANOVA) but not in
the blood (p=0.47, Figure 4b). The comparison of pairs of vsp
gene copy numbers in the brain showed more vsp2 than vsp3, vsp13
or vsp27, and more vsp3 than vsp13 (all p,0.05 using Bonferroni’s
correction). There appeared to be more vsp13 than vsp3 gene copy
number in the plasma (Figure 4b), although the difference did not
reach statistical significance: the mean (SD) 2
2DDCt was 0.73(0.88)
for vsp13 and 0.43(0.7) for vsp3. This could be explained in part by
the higher amount of Bh3 than Bh13 spirochetes in the original
inoculum (Table S3). We did not find any correlation between the
vsp gene copy number in the brain and the plasma (correlation
coefficient=0.10). These results revealed that the two B. hermsii vsp
genes corresponding to serotypes from the middle branch of the
Vsp homology dendrogram, BhVsp2 and BhVsp3, showed greater
localization to the brain than the two belonging to the upper
(BhVsp27) or lower (BhVsp13) branches.
Computer homology modeling of B. hermsii Vsp domes
Next we compared the structure and electrostatic field potential
of the Vsp domes from Bh2, Bh3, Bh13, and Bh27. For this we did
computer homology modeling as before using the known crystal
structures of Vsp1 of B. turicatae and OspC from B. burgorferi. The
results revealed that all four B. hermsii Vsp domes are more similar
Table 3. Paired comparison of clinical severity scores between groups of SCID mice persistently infected with serotypes 1 (Bt1) or
2 (Bt2) of Borrelia turicatae or serotypes 3 (Bh3) or 13 (Bh13) of Borrelia. hermsii
a.
Clinical Involvement Bt2 vs Bt1 Bt2 vs Bh3 Bt2 vs Bh13 Bt1 vs Bh3 Bh13 vs Bt1 Bh13 vs Bh3
Skin Bt2.Bt1 Bt2.Bh3 Bt2=Bh13 Bt1.Bh3 Bh13.Bt1 Bh13.Bh3
p value
b 0.008 0.018 1 0.018 0.008 0.018
Eyes Bt2.Bt1 Bt2.Bh3 Bt2.Bh13 Bt1=Bh3 Bh13=Bt1 Bh13=Bh3
p value 0.011 0.018 0.04 0.31 0.85 0.5
Joints Bt2.Bt1 Bt2.Bh3 Bt2.Bh13 Bt1=Bh3 Bh13=Bt1 Bh13=Bh3
p value 0.017 0.029 0.013 1 0.32 0.25
Spontaneous activity Bt2.Bt1 Bt2=Bh3 Bt2=Bh13 Bt1=Bh3 Bh13.Bt1 Bh13.Bh3
p value 0.011 0.19 0.18 0.07 0.011 0.05
aGroups of 4 SCID mice each were inoculated intraperitoneally with 10
3 spirochetes of each serotype and upon onset of clinical disease examined on 4 different
occasions over a 3 week period by a masked examiner to measure disease severity scores in the skin, eyes, joints, and spontaneous activity. A group of uninfected mice
was included as negative control (not shown). The sign ‘‘.’’ indicates significantly higher disease severity score with the corresponding p value shown below.
bP value for the difference in mean (SD) severity scores for each clinical measure between each pair of serotypes shown above (t-test).
doi:10.1371/journal.pone.0007597.t003
Table 4. Efficiency of Taqman real time PCR Gene Expression Assays used in the study.
Assay Taqman assay Mean Efficiency 95% Confidence Interval
Borrelia 16S rRNA Singleplex 98.10% 96.3%–99.8%
Bhvsp3 Singleplex 99.00% 88.3%–109.8%
Bhvsp13 Singleplex 100.00% 95.9%–104.1%
Bhvsp2 Singleplex 101.10% 97.8%–104.0%
Bhvsp27 Singleplex 99.00% 95.4%–100.9%
Borrelia 16S rRNA Multiplex
a 96.10% 88.5%–103.7%
Bhvsp3 Multiplex 97.80% 88.2%–107.3%
Bhvsp13 Multiplex 96.30% 86.7%–105.8%
Bhvsp2 Multiplex 99.00% 95.8%–102.0%
Bhvsp27 Multiplex 98.60% 96.6%–100.6%
aMultiplex refers to simultaneous amplification of a Borrelia gene and the mouse housekeeping gene (18S rRNA) in the same well.
doi:10.1371/journal.pone.0007597.t004
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The B. hermsii Vsp modeling also revealed that all 4 have multiple
sites capable of participating in chelation of ions near their top,
including a negative charge patch in electrostatic potential plus the
presence of Asp, His or Cys residues (Figure 5, lower panel).
Discussion
Here we studied using a murine model whether serotypes of the
RF spirochete B. hermsii exhibit differences in their pathogenicity
and pathogen load in blood and brain. The results revealed that,
similar to what has been observed for the RF spirochete B. turicatae,
for most aspects of clinical disease severity, peak bacteremia, and
dissemination to the brain this was in deed the case. Although in
most aspects the clinical manifestations of infection with B. hermsii
serotypes resembled those observed with B. turicatae, one notable
exception was tibiotarsal arthritis which occurs to a significant
degree only with Bt2 (Figure 3B and Table 3). In this sense it is
also interesting that the computer homology modeling of Vsp
domes showed that the BtVsp2 dome seems to be the oddball
among all the Vsp domes we studied (Figures 1 and 5). This is the
largest in vivo study comparing the pathogenicity of individual
serotypes of any RF spirochete. An intriguing observation from
Figure 4. B. hermsii vsp gene copy number in brain and blood.
The ability of serotypes 2, 3, 13, and 27 of B. hermsii to disseminate to
the brain was examined by measuring the relative vsp gene copy
number by TaqMan PCR in brain and plasma of SCID mice 2 weeks after
intraperitoneal inoculation with a mixed relapse serotype population
(see methods for details). Results were analyzed using the DDCt
method adjusting for the amount of input DNA using the mouse
chromosomal gene for 18S rRNA and graphed as the log 2 negative
number (2
2DDCt) so that higher values present higher gene copy
number relative to the borrelial chromosomal gene for 16S rRNA.
Results shown for plasma represent multiplex and for brain singleplex
because the sensitivity for detection of borrelial genes in the brain is
1.5–3.6 fold lower with multiplex due to the abundance of host DNA.
There was significant variability in gene copy number in brain (panel A,
p,0.01 by one way ANOVA) but not in plasma (panel B, p=0.47).
Notice the higher gene copy number in the brain for Bhvsp2 compared
to Bhvsp3, Bhvsp13,o rBhvsp27, and for Bhvsp3 compared to Bhvsp13
(all p,0.05 after Bonferroni’s correction).
doi:10.1371/journal.pone.0007597.g004
Figure 5. Computer homology modeling of B. hermsii Vsp’s. Vsp
dome regions were modeled based on two crystal structures of BtVsp1
and individual crystal structures from OspC from 3 different Borrelia
burgdorferi strains. The upper panel shows the axial (dome) views of the
Vsp proteins for B. hermsii serotypes 2 (BhVsp2), 3 (BhVsp3), 13
(BhVsp13), and 27 (BhVsp27). Each amino acid corresponds to a letter
and a color which represents their polarity with red for high polarity
and dark blue for low polarity. The lower panel shows the
corresponding electrostatic potential fields for each axial region with
the red color representing negative and the blue color positive
electrostatic potential. Notice the more pronounced negative electro-
static potential of BhVsp2 and BhVsp3 (D=aspartic acid, E=glutamic
acid, K=lysine, R=arginine, H=histidine, S=serine, T=threonine,
N=asparagine, Q=glutamine, A=alanine, G=glycine, P=proline,
L=leucine, I=isoleucine, V=valine).
doi:10.1371/journal.pone.0007597.g005
Borrelia hermsii Serotypes
PLoS ONE | www.plosone.org 7 October 2009 | Volume 4 | Issue 10 | e7597this structure/function study is that for many of the variables
examined there was a good correlation between the Vsp dome
homology dendrogram and the clinical manifestations of the
infection and pathogen load in fluids and/or tissues. Probably the
best example of this is that B. hermsii serotypes that clustered in the
middle branch of the Vsp dome dendrogram, like Bh2 and Bh3,
shared similar low systemic virulence and higher brain dissemi-
nation with Bt1, the one B. turicatae serotype we examined from the
middle branch of the dendrogram. However, this study also has
some important limitations, including that the analysis of serotypes
was limited to 4 of the known Vsp serotypes of the HS1 strain of B.
hermsii, that we did not study any of the Vlp serotypes, and that the
clinical phenotype was studied in groups of only 4 SCID mice
each.
The higher neuroinvasiveness of the 3 serotypes we examined
from the middle branch of the Vsp dome dendrogram, Bh2, Bh3,
and Bt1, relative to the three serotypes from the other two
branches, Bh13, Bh27, and Bt2, suggests that there is something
about the structure of the Vsp dome that may facilitate
dissemination to the brain. However, confirmation of our findings
can only be achieved via genetic manipulation of the expressed vsp
gene in RF spirochetes, which is currently not possible. Another
interesting observation is the lack of correlation between the
intensity of peak bacteremia and the pathogen load in the brain
(Figure 4), which has been observed before with Bt1 and Bt2.
Because these results were obtained in SCID mice that are
deficient in B and T cells we interpret this observation as evidence
of differences in dissemination from blood to brain among
serotypes and not simply as the result of niche selection in an
immunoprivileged organ [22,37]. These results are also consistent
with our previous observation that some relapse serotypes of B.
hermsii are found in blood but not brain during first relapse in
immunocompetent Balb/c mice [22].
The computer homology modeling of Vsp domes revealed
important differences in their polarity: although the overall Vsp
structures were similar, the charge in the region that projects away
from the spirochetes surface was very different between BtVsp2
and all the others (Figures 1 and 5). It is possible that polar amino-
acids at the Vsp dome are involved in the interaction of RF
spirochetes with eukaryotic cells. One possibility is that serotypes
with less polar domes, and hence hydrophobic, like Bt2, would
prefer interactions with proteins richer in non-polar amino acids
such as those of collagenous tissues [38]. Consistent with this is the
previous finding that Bt2 binds to glycosaminoglycans more
efficiently than Bt1 and that recombinant BtVsp2, but not BtVsp1,
binds to heparin and dermatan sulphate [39]. In the dendrogram,
the BtVsp2 dome clustered next to the Vsp dome for the tick-
associated protein, BhVsp33, also referred to as variable tick
protein or Vtp [40]. It would be interesting to compare the Vsp
dome structures of these 2 serotypes.
Bt2 originated from Bt1 through a gene conversion during
chronic infection in one SCID mice that had been inoculated with
tick homogenates responsible for an outbreak of tick-borne RF
with prominent neuroborreliosis [8]. Despite an extensive
interplasmidic duplication, the only detectable difference between
Bt1 and Bt2 is whether their major expressed outer membrane
lipoprotein is Vsp1 or Vsp2 [24]. Processed Vsp2 is distinguished
from other Vsp and OspC proteins of Lyme disease spirochetes by
a highly predicted isoelectric point [24]. Previously, circular
dichroism spectra comparison of BtVsp1, Bt2Vsp2, BhVsp26, and
B. burgdorferi OspC revealed similar, highly alpha-helical secondary
structures in all of them [19]. Furthermore, all four proteins
aggregated as dimers in solution and formed protease-resistant
cores [19]. These observations indicate that Vsp and OspC
proteins have a common compact fold and that their established
functions are likely based on localized polymorphisms at their
dome regions [21].
There are other known human pathogens that use variation of
outer membrane proteins for modulation of tissue dissemination
during infection. One example is the agent of malaria, Plasmodium
falciparum, that sequesters infected erythrocytes in tissue microves-
sels that can be found in the brain, liver, lungs, kidneys, and other
tissues; interestingly, antigenically different parasite populations
exhibit different sequestration profiles [41]. Another example is
Neisseria gonorrhoeae, where the pili responsible for adherence to
different types of eukaryotic cells are composed of repeating pilin
subunits; analysis of these pilin subunits has shown that there are
constant, semivariable, and hypervariable regions and that
hypervariable regions exhibiting differing amino acid compositions
and isoelectric points result in variable adherence to different types
of human cells [41]. In B. burgdorferi, the structures of OspC among
tick populations are as diverse as the Vsp proteins in RF borrelias
and could provide a method to modulate dissemination upon
entering the mammalian host. Indeed, it has been demonstrated
that OspC is required for mammalian infection but not for tick
colonization, indicating a potential role for OspC in adapting the
spirochete to the mammalian environment as well as conferring an
ability to withstand a dramatic transition of environments [42].
Other studies that support a role for OspC in environmental
adaptation showed, by directly injecting OspC mutants into host
areas that normally become persistently infected, that the lack of
fully formed OspC protein prevents establishment of infection
[43,44]. It has been speculated in the case of OspC that this role
may be related to immune evasion, particularly the evasion of
innate immunity that would normally destroy invading spirochetes
before they have a chance to establish infection [44]. The fact that
both Vsp and OspC expression is stopped via modulation of gene
expression and not by plasmid loss [45] supports a model within
the genus Borrelia for switching expression of outer membrane
proteins to adapt to different environments. The findings from the
present study extend the previous observations in B. turicatae to B.
hermsii adding to the body of evidence suggesting that variation of
outer membrane proteins in spirochetes may be an important
determinant of the clinical manifestations of these infections.
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